bioengineer.org /1 week ago

ALDH2 Suppresses Multiple Myeloma Progression by Restraining the E2F Signaling Pathway

Researchers found that ALDH2 acts as an independent favorable prognostic biomarker in multiple myeloma, curbing cancer cell proliferation and promoting apoptosis through suppressio...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.